Amikacin serum protein binding in spinal cord injury
- 31 December 1991
- journal article
- Published by Elsevier in Life Sciences
- Vol. 49 (2), PL1-PL5
- https://doi.org/10.1016/0024-3205(91)90030-f
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Protein Binding: What Does it Mean?DICP, 1989
- Amikacin Pharmacokinetics in Patients with Spinal Cord InjuryPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 1988
- Drug Distribution and BindingThe Journal of Clinical Pharmacology, 1986
- Ultrafiltration in Serum Protein Binding DeterminationsJournal of Pharmaceutical Sciences, 1981
- The significance of protein binding of antibiotics in antibacterial chemotherapyJournal of Antimicrobial Chemotherapy, 1980
- Influence of Protein Binding of Antibiotics on Serum Pharmacokinetics and Extravascular Penetration: Clinically Useful ConceptsClinical Infectious Diseases, 1980
- UK-18892, a New Aminoglycoside: An In Vitro StudyAntimicrobial Agents and Chemotherapy, 1978
- Amikacin in Treatment of Infections Caused by Gram-Negative Bacteria Resistant to Gentamicin and Other Aminoglycosides: Clinical and Bacteriologic ResultsThe Journal of Infectious Diseases, 1976
- Amikacin Therapy for Severe Gram-Negative SepsisAnnals of Internal Medicine, 1975
- The value of postural reduction in the initial management of closed injuries of the spine with paraplegia and tetraplegiaSpinal Cord, 1969